Equity
-€49,122
Debts exceed assets in financial year 2025.
Revalis
Lifetime
1 annual account with figurespeak €25,247 (2025)
€25,247
lowest -€50,122 (2025)
-€50,122
peak -€49,122 (2025)
-€49,122
€1.1m
Board2 names since 2024
2 directors and 1 other
Documentsfilings and deeds
17-07-202614 days before the deadline
2025micro format
Loss of €50,1221 establishment registeredFirst year with figures
Key points
from the 2025 annual accountsDebts
€1.1m 105% of the balance sheet
Financial debts 88%Suppliers 2%Taxes and wages 0%Other 10%
Of this, €126,892 falls due within a year.
Position in the sector
-4.9%
Lower solvency than 95% of companies in human health. Sector median 63.0% · 21,311 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 1,252 companies had the same profile as Revalis has now. Each dot stands for 4 companies, two years later.
96.5%
were still trading
2.2%
stopped another way
1.0%
went bankrupt
Another 0.3% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,252 companies, not a prediction for Revalis. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director
Director
- founderdeed of 03-10-2024
- 25 sharesdeed of 03-10-2024
- 25 sharesdeed of 03-10-2024
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1014408974
First establishment
Vaartstraat 60, Ingelmunster
Incorporation
Founding capital of €1,000, 50 shares · Founders: and · Appointments: (director) and (director) · published on 03-10-2024 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Revalis Kortrijk | €1.0m | €25,247 | -4.9% | - |
| Dokter Charlien Dewulf Aalst | €0.8m | €23,664 | 1.2% | - |
| Dr. Andreas Lycke Oostkamp | €0.6m | €26,677 | -5.5% | - |
| RDCMed Verviers | €0.6m | €21,347 | 1.2% | - |
| Dr. Seher Avci Houthalen-Helchteren | €0.5m | €28,197 | 4.9% | - |
| De Vossenkuijl Hoogstraten | €0.7m | €32,055 | 85.0% | - |
| Convallaria Oud-Heverlee | €0.5m | €23,240 | 4.2% | - |
These companies have the same main activity as Revalis: general medical practice (NACE 86210). They are comparable in size and age: total assets between €451,000 and €760,000, founded between 2022 and 2025.
Official details
Source: KBO- Status
- Active since 01-10-2024Normal situation
- Activity
- General medical practiceNACE 86210
- Establishment unit
- 2.367.080.7068770 Ingelmunster, since 01-01-2025
- Financial year end
- 31 December
- Peppol
- Reachable since 10-01-2025
Annual accounts 2025
- ≈ €78,000estimated
- €1.0m
- Filing
- Filed on 17-07-2026, 14 days before the end of the filing period
Insights on Revalis
Revalis has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€49,122) and a net result of -€50,122.
Its solvency ranks better than 5% of 21,311 sector peers (NACE 86, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Revalis
- What is the company number of Revalis?
- The company number of Revalis is 1014.408.974. The VAT number is the same number with BE in front: BE 1014.408.974.
- Where is Revalis based?
- The registered office is at Rijsland 19, 8501 Kortrijk.Company details
- What does Revalis do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of Revalis?
- Revalis is a private limited company (BV).
- When was Revalis founded?
- Revalis was founded on 01-10-2024.
- Is Revalis still active?
- Yes, Revalis is an active enterprise in the KBO register.
- What is the turnover of Revalis?
- The turnover in financial year 2025 is ≈ €78,000. This figure is estimated from the gross margin of €25,247 and 47 comparable companies (NACE 86). It probably lies between €56,000 and €110,000.Financials
- Is Revalis profitable?
- In financial year 2025, Revalis made a loss of €50,122.
- Where can I find the annual accounts of Revalis?
- Revalis filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark Estimate what this company is worth.Value indication
See how customers, suppliers and banks see your own company and what to improve first.